Lakewood-Amedex Biotherapeutics Inc.
LABTNasdaqHealthcare · Pharmaceutical Preparations · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 148,551 | 1.0 | +96.2% |
| Apr 30, 2026 | 75,707 | 1.0 | +100.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recentEvents the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 424B3PROSPECTUS SUPPLEMENTMay 26, 2026
- 424B3PROSPECTUS SUPPLEMENTMay 26, 2026
- 10-QQUARTERLY REPORTMay 22, 2026
- 424B4PROSPECTUSMay 14, 2026
- EFFECTMay 13, 2026
- 4May 6, 2026
- 3May 6, 2026
- 3May 1, 2026
- 3May 1, 2026
- 3May 1, 2026
- 3May 1, 2026
- S-1REGISTRATION STATEMENTMay 1, 2026
- 424B3PROSPECTUS SUPPLEMENTApr 30, 2026
- 8-KCURRENT REPORTApr 28, 2026
- 424B4PROSPECTUSApr 23, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.